Mads Daugaard

This study identifies stromal chondroitin-4-sulfate as a determinant of platinum response in ovarian cancer through glycomics profiling and functional validation.

This study identifies rare germline variants associated with metastatic prostate cancer using an extreme phenotype cohort and validates their functional impact.

This study develops CAR T cells specific to oncofetal chondroitin sulfate, demonstrating their ability to target and eliminate tumor cells in vitro and improve survival in vivo.

The paper shows androgen-regulated ESRP2 transcription controls alternative splicing in prostate cancer, with implications for metastasis.